Avant BrandsFRA:1BU 37 ROA % is -28.87% as of Feb. 2026. GuruFocus rates FRA:1BU with a GF Score™ of 37/100 and a GF Value™ of €0.70 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,003 Drug Manufacturers companies, Avant Brands ranks worse than 87.14% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Avant Brands's annualizedNet Income for the quarter that ended in Feb. 2026 was €-8.52 Mil.
Avant Brands's average Total Assets over the quarter that ended in Feb. 2026 was €29.49 Mil. Therefore, Avant Brands's annualized ROA % for the quarter that ended in Feb. 2026 was -28.87%.
The historical rank and industry rank for Avant Brands's ROA % or its related term are showing as below:
FRA:1BU'
s ROA % Range Over the Past 10 Years
Min: -230 Med: -23.62 Max: -6.78
Current: -24.43
During the past 13 years, Avant Brands's highest ROA % was -6.78%. The lowest was -230.00%. And the median was -23.62%.
FRA:1BU's ROA % is ranked worse than 87.14% of 1003
companies
in the Drug Manufacturers industry
Industry Median: 2.69
vs FRA:1BU: -24.43
Avant Brands (FRA:1BU) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Feb. 2026) net income data. The Revenue data used here is four times the quarterly (Feb. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Avant Brands ROA % Related Terms
Avant Brands ROA % Historical Data
* Premium members only.
The historical data trend for Avant Brands's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Avant Brands's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avant Brands ROA % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Avant Brands's ROA % distribution charts can be found below:
* The bar in red indicates where Avant Brands's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Feb. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Avant Brands (FRA:1BU) has a ROA % of -28.87% as of Feb. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Avant Brands and its competitors. According to the industry distribution chart, Avant Brands ranks #874 out of 1003 companies in the Drug Manufacturers industry, placing it in the top 87.1%.
Is Avant Brands' ROA % too high?
Avant Brands' current ROA % is -28.87%. Based on the distribution chart, Avant Brands ranks #874 out of 1003 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Avant Brands has a GF Score™ of 37/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Avant Brands' ROA % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Avant Brands ranks #874 out of 1003 companies for ROA %. This places Avant Brands in the lower half of its industry. The industry median ROA % is 2.69. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Drug Manufacturers company?
The median ROA % among Drug Manufacturers companies is 2.69, based on 1,003 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Avant Brands and its competitors. For the Drug Manufacturers industry, the median ROA % is 2.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avant Brands's current ROA % is -28.87%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avant Brands stock overvalued right now?
Based on GuruFocus' analysis, Avant Brands (FRA:1BU) is currently considered Possible Value Trap. The stock's GF Value™ is €0.70, compared to a current price of €0.33 — trading 52.3% below its estimated fair value. The current ROA % is -28.87%. Avant Brands' overall GF Score™ is 37/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Avant Brands (FRA:1BU), the current ROA % is -28.87% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Avant Brands (FRA:1BU) Overvalued in 2026?
Based on GuruFocus' analysis, Avant Brands stock appears to be undervalued.
The current stock price of €0.33 is trading 52.3% below its estimated GF Value™ of €0.70.
GuruFocus considers Avant Brands to be Possible Value Trap.
Key valuation signals for FRA:1BU:
ROA %: -28.87%
GF Value™: €0.70 vs. price of €0.33 (52.3% below fair value)
No single metric tells the full story. See the FRA:1BU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Avant Brands Inc operating in the cannabis industry, engages in the cultivation, production, marketing, and sale of cannabis products. Its product portfolio mainly consists of dried cannabis flower and related cannabis products, with the company managing the entire value chain from cultivation and harvesting to processing, packaging, and distribution, generating revenue upon delivery of products to customers. It operates in Canada.
37GF Score
Get the complete analysis for FRA:1BU
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:1BU has been successfully added to your 
